• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酮 II-A 可减轻并稳定高胆固醇饮食喂养的载脂蛋白 E 基因敲除小鼠的动脉粥样硬化斑块。

Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.

机构信息

Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University (HEMC), 132 East Wai-huan Road, Guangzhou, Guangdong, China.

出版信息

Arch Biochem Biophys. 2011 Nov;515(1-2):72-9. doi: 10.1016/j.abb.2011.08.006. Epub 2011 Aug 26.

DOI:10.1016/j.abb.2011.08.006
PMID:21889487
Abstract

Tanshinone II-A (Tan), a bioactive diterpene isolated from Salvia miltiorrhiza Bunge (Danshen), possesses anti-oxidant and anti-inflammatory activities. The present study investigated whether Tan can decrease and stabilize atherosclerotic plaques in Apolipoprotein-E knockout (ApoE(-/-)) mice maintained on a high cholesterol diet (HCD). Six week-old mice challenged with a HCD were randomly assigned to 4 groups: (a) C57BL/6J; (b) ApoE(-/-); (c) ApoE(-/-)+Tan-30 (30 mg/kg/d); (d) ApoE(-/-)+Tan-10 (10mg/kg/d). After 16 weeks of intervention, Tan treated mice showed decreased atherosclerotic lesion size in the aortic sinus and en face aorta. Furthermore, immunohistochemical analysis revealed that Tan rendered the lesion composition a more stable phenotype as evidenced by reduced necrotic cores, decreased macrophage infiltration, and increased smooth muscle cell and collagen contents. Tan also significantly reduced in situ superoxide anion production, aortic expression of NF-κB and matrix metalloproteinase-9 (MMP-9). In vitro treatment of RAW264.7 macrophages with Tan significantly suppressed oxidized LDL-induced reactive oxygen species production, pro-inflammatory cytokine (IL-6, TNF-α, MCP-1) expression, and MMP-9 activity. Tan attenuates the development of atherosclerotic lesions and promotes plaque stability in ApoE(-/-) mice by reducing vascular oxidative stress and inflammatory response. Our findings highlight Tan as a potential therapeutic agent to prevent atherosclerotic cardiovascular diseases.

摘要

丹参酮 II-A(Tan)是从丹参(Danshen)中分离得到的一种生物活性二萜,具有抗氧化和抗炎作用。本研究旨在探讨 Tan 是否可以减少和稳定高胆固醇饮食(HCD)维持的载脂蛋白 E 基因敲除(ApoE(-/-))小鼠的动脉粥样硬化斑块。6 周龄的 HCD 挑战小鼠被随机分为 4 组:(a)C57BL/6J;(b)ApoE(-/-);(c)ApoE(-/-)+Tan-30(30mg/kg/d);(d)ApoE(-/-)+Tan-10(10mg/kg/d)。干预 16 周后,Tan 治疗组小鼠主动脉窦和全主动脉粥样硬化病变面积减小。此外,免疫组织化学分析显示,Tan 使病变组成更稳定,表现为坏死核心减少、巨噬细胞浸润减少、平滑肌细胞和胶原含量增加。Tan 还显著减少主动脉原位超氧阴离子产生、NF-κB 和基质金属蛋白酶-9(MMP-9)的表达。体外用 Tan 处理 RAW264.7 巨噬细胞可显著抑制氧化型 LDL 诱导的活性氧产生、促炎细胞因子(IL-6、TNF-α、MCP-1)表达和 MMP-9 活性。Tan 通过减少血管氧化应激和炎症反应,减轻 ApoE(-/-)小鼠动脉粥样硬化病变的发展,促进斑块稳定。我们的研究结果强调了 Tan 作为预防动脉粥样硬化性心血管疾病的潜在治疗药物的作用。

相似文献

1
Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.丹参酮 II-A 可减轻并稳定高胆固醇饮食喂养的载脂蛋白 E 基因敲除小鼠的动脉粥样硬化斑块。
Arch Biochem Biophys. 2011 Nov;515(1-2):72-9. doi: 10.1016/j.abb.2011.08.006. Epub 2011 Aug 26.
2
Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.丹参酮 II-A 通过减少细胞内超氧自由基生成和 NF-κB 激活抑制氧化型 LDL 诱导的巨噬细胞 LOX-1 表达。
Transl Res. 2012 Aug;160(2):114-24. doi: 10.1016/j.trsl.2012.01.008. Epub 2012 Feb 2.
3
The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.1a型血管紧张素II受体缺乏对高胆固醇血症诱导的动脉粥样硬化的长期影响。
Hypertens Res. 2008 Aug;31(8):1631-42. doi: 10.1291/hypres.31.1631.
4
[Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].[瑞舒伐他汀对载脂蛋白E基因敲除小鼠动脉粥样硬化病变的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug;39(8):743-8.
5
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.聚(ADP - 核糖)聚合酶抑制可减小载脂蛋白E缺陷小鼠的动脉粥样硬化斑块大小并促进斑块稳定性相关因子:对巨噬细胞募集、核因子 - κB核转位及泡沫细胞死亡的影响
Circulation. 2007 May 8;115(18):2442-50. doi: 10.1161/CIRCULATIONAHA.106.668756. Epub 2007 Apr 16.
6
Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.高脂饮食喂养的缺乏白细胞介素-18 的载脂蛋白 E 基因敲除小鼠动脉粥样硬化损伤增加和 Th17 增加。
Mol Immunol. 2009 Nov;47(1):37-45. doi: 10.1016/j.molimm.2008.12.032. Epub 2009 Feb 8.
7
Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.内皮素-1 过表达加剧载脂蛋白 E 基因敲除小鼠的动脉粥样硬化并诱导其发生主动脉瘤。
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2306-15. doi: 10.1161/ATVBAHA.113.302028. Epub 2013 Jul 25.
8
Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.非洛地平抑制高胆固醇饮食载脂蛋白E基因敲除小鼠动脉粥样硬化的分子机制
J Cardiovasc Pharmacol. 2008 Feb;51(2):188-95. doi: 10.1097/FJC.0b013e31815f2bce.
9
Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.氨氯地平通过抗炎和抗氧化应激作用使动脉粥样硬化消退。
Hypertens Res. 2006 Jun;29(6):457-66. doi: 10.1291/hypres.29.457.
10
Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.硫化氢调节载脂蛋白 E 敲除小鼠的血管内质网应激。
Chin Med J (Engl). 2011 Nov;124(21):3460-7.

引用本文的文献

1
Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials.用于动脉粥样硬化的中成药:随机对照试验的系统评价与Meta分析
J Tradit Chin Med. 2024 Dec;44(6):1082-1090. doi: 10.19852/j.cnki.jtcm.2024.06.001.
2
Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review.揭示丹参酮作为心血管疾病新斗士的保护作用机制:系统评价。
Cardiovasc Toxicol. 2024 Dec;24(12):1467-1509. doi: 10.1007/s12012-024-09921-x. Epub 2024 Sep 22.
3
Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis.
丹参酮IIA:一种用于治疗动脉粥样硬化的中药成分。
Front Pharmacol. 2023 Dec 1;14:1321880. doi: 10.3389/fphar.2023.1321880. eCollection 2023.
4
Research progress in the quality evaluation of Salvia miltiorrhiza based on the association of 'morphological features - functional substances - pharmacological action - clinical efficacy'.基于“形态特征-功能成分-药理作用-临床疗效”关联的丹参质量评价研究进展
Heliyon. 2023 Sep 25;9(10):e20325. doi: 10.1016/j.heliyon.2023.e20325. eCollection 2023 Oct.
5
Tanshinone IIA attenuates valvular interstitial cells' calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress.丹参酮IIA通过减轻内质网应激来减轻氧化型低密度脂蛋白诱导的瓣膜间质细胞钙化。
Open Med (Wars). 2023 Sep 25;18(1):20230797. doi: 10.1515/med-2023-0797. eCollection 2023.
6
Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells.丹参酮 IIA 和黄芪甲苷 IV 通过抑制 miR-223/JAK2/STAT1 信号通路缓解脂多糖诱导的髓核细胞损伤。
Dis Markers. 2021 Oct 12;2021:6554480. doi: 10.1155/2021/6554480. eCollection 2021.
7
Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.丹参酮 IIA 在相关疾病中的药理作用及机制。
Drug Des Devel Ther. 2020 Nov 5;14:4735-4748. doi: 10.2147/DDDT.S266911. eCollection 2020.
8
Investigation of the Lipid-Lowering Mechanisms and Active Ingredients of Danhe Granule on Hyperlipidemia Based on Systems Pharmacology.基于系统药理学的丹荷颗粒对高脂血症的降脂机制及活性成分研究
Front Pharmacol. 2020 May 6;11:528. doi: 10.3389/fphar.2020.00528. eCollection 2020.
9
Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries.氯沙坦阻断肾素血管紧张素系统可减轻高胆固醇血症诱导的炎症和氧化损伤。
Redox Rep. 2020 Dec;25(1):51-58. doi: 10.1080/13510002.2020.1763714.
10
Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway.丹参酮 IIA 通过调控 miR-145/GSDMD 信号通路增强 HeLa 细胞焦亡并抑制细胞增殖。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200259.